Additional assessment and/or laboratory testing may be indicated prior to therapy based on recent or current use of a very lowcalorie diet, prior bariatric surgery, celiac disease, other inflammatory conditions predisposing to nutrient deficiency, or prior nutrient deficiency [57, 128]
Cardiovasc Res 82:448457
Zealand is a Danish biotechnology company with 25 years of expertise in discovering, designing, and developing peptide-based drugs
"On April 22 this year, WADA indicated in a statement that AOD-9604 was a banned substance still under pre-clinical and clinical development and that it had not been approved for therapeutic use by any government health authority in the world
Diabetologia 63 , 21942204 (2020)
Factors that contribute to the choice of biologic therapy include route of administration, extraintestinal manifestations of disease, side-effect profile and need for rapid induction